These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24164191)

  • 1. Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate.
    Seignez A; Kohli É; Garrido C; Seigneuric R
    Curr Med Chem; 2014; 21(2):153-63. PubMed ID: 24164191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
    Strbo N; Podack ER
    Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of renal cell carcinoma-derived peptides associated with GP96.
    Li HZ; Li CW; Li CY; Zhang BF; Li LT; Li JM; Zheng JN; Chang JW
    Technol Cancer Res Treat; 2013 Aug; 12(4):285-93. PubMed ID: 23448575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of anti-tumor immunity by HSP gp96-peptide complexes].
    Zhang TY; Niu JX; Lin L; Huang XC; Gu JY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):17-20. PubMed ID: 15629075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
    Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
    Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94).
    Linderoth NA; Popowicz A; Sastry S
    J Biol Chem; 2000 Feb; 275(8):5472-7. PubMed ID: 10681525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96.
    Podack ER; Raez LE
    Expert Opin Biol Ther; 2007 Nov; 7(11):1679-88. PubMed ID: 17961091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of peptide loading by the tumor rejection antigen/heat shock chaperone gp96 (GRP94).
    Sastry S; Linderoth N
    J Biol Chem; 1999 Apr; 274(17):12023-35. PubMed ID: 10207025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Toll-Like Receptors with the Molecular Chaperone Gp96 Is Essential for Its Activation of Cytotoxic T Lymphocyte Response.
    Liu W; Chen M; Li X; Zhao B; Hou J; Zheng H; Qiu L; Li Z; Meng S
    PLoS One; 2016; 11(5):e0155202. PubMed ID: 27183126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The killing effect of cytotoxic T lymphocytes on esophageal adenocarcinoma cells mediated by gp96-peptide complexes].
    Ma LP; Pan XY; Li N; Liu YJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):525-8. PubMed ID: 15489936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.
    Yedavelli SP; Guo L; Daou ME; Srivastava PK; Mittelman A; Tiwari RK
    Int J Mol Med; 1999 Sep; 4(3):243-8. PubMed ID: 10425272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.
    Strbo N; Garcia-Soto A; Schreiber TH; Podack ER
    Immunol Res; 2013 Dec; 57(1-3):311-25. PubMed ID: 24254084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.
    Baker-LePain JC; Sarzotti M; Nicchitta CV
    J Immunol; 2004 Apr; 172(7):4195-203. PubMed ID: 15034032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.